Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy: Miniperspective

[Image: see text] Cyclin dependent kinase (CDK) inhibitors have been the topic of intense research for nearly 2 decades due to their widely varied and critical functions within the cell. Recently CDK9 has emerged as a druggable target for the development of cancer therapeutics. CDK9 plays a crucial...

Descripción completa

Detalles Bibliográficos
Autores principales: Sonawane, Yogesh A., Taylor, Margaret A., Napoleon, John Victor, Rana, Sandeep, Contreras, Jacob I., Natarajan, Amarnath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2016
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636177/
https://www.ncbi.nlm.nih.gov/pubmed/27171036
http://dx.doi.org/10.1021/acs.jmedchem.6b00150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636177/
https://www.ncbi.nlm.nih.gov/pubmed/27171036
http://dx.doi.org/10.1021/acs.jmedchem.6b00150

Ejemplares similares